NanoDx Collaborates with IBM Research on Sensors for Rapid Diagnostic Testing
NanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read MorePosted by Chris Wolski | Jul 14, 2021 | Covid 19, POC Rapid Assays, Rapid Assays, Sepsis, Stroke |
NanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read MorePosted by Chris Wolski | Jul 14, 2021 | Rapid Assays |
A new study has found that lateral flow tests detect COVID-19 with similar accuracy to laboratory-based PCR tests.
Read MorePosted by Melanie Hamilton-Basich | Jul 14, 2021 | Covid 19, Flu & Respiratory Infections |
GT Molecular has started shipping its sensitive PCR tests to monitor the coronavirus Delta variant (B.1.617.2) as well as testing and PCR kits for the detection of Influenza A and B.
Read MorePosted by Melanie Hamilton-Basich | Jul 13, 2021 | Covid 19 |
Seegene’s new COVID-19 variant diagnostic test is capable of screening newly emerging virus variants including the Delta and the Delta Plus that have become the dominant versions of the SARS-CoV-2 virus circulating around the world.
Read MorePosted by Melanie Hamilton-Basich | Jul 13, 2021 | Covid 19 |
Ortho’s new quantitative COVID-19 IgG antibody test targets the S1 spike protein and is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test offers 100% specificity and excellent sensitivity.
Read More